The Manila Times

Kymera Therapeutics Presents New Preclinical Data for KT-579, a First-in-Class, Oral IRF5 Degrader, at the American College of Rheumatology Annual Meeting

KT-579, a potent, selective, oral degrader of IRF5, demonstrated broad activity across multiple preclinical models of lupus and rheumatoid arthritis (RA), with activity comparable or superior to appro ...

TfL's former director of strategy reveals how to fix Britain’s broken railways - and why trains need more first-class carriages

British rail travel has been on a downward trajectory in recent days. From soaring ticket costs to the increasing strain of ...

Kymera Therapeutics, Inc.: Kymera Therapeutics Presents New Preclinical Data for KT-579, a First-in-Class, Oral IRF5 Degrader, at the American College of Rheumatology Annual ...

KT-579, a potent, selective, oral degrader of IRF5, demonstrated broad activity across multiple preclinical models of lupus and rheumatoid arthritis (RA), with activity comparable or superior to appro ...

TVS Raider 125 - 2025 Price List, Design, Mileage, Engine, Colours And More

The TVS Raider 125 is a sporty commuter bike that combines style, performance, and smart features. Powered by a 124.8cc ...

What is the ‘Golden Fleet’ of navy ships that Trump wants to counter China with?

President Donald Trump’s administration is advancing plans for a sweeping overhaul of the US Navy under the proposed ‘Golden ...

How Will The Boeing 777X Coexist With The 787 & Airbus A350?

The 777-9 has a typical capacity of 426 passengers in two cabin classes, putting it well ahead of the A350 and 787. While the ...

5 Of The Biggest Regrets Customers Have After Buying The Hyundai Kona

From rattling interiors and noisy driving to spontaneous fires, some drivers have found the Hyundai Kona to be less than the ...

The Aircraft Set To Replace Delta Air Lines’ Iconic Boeing 767s

Delta has owned a variety of the 767 series and currently maintains the largest existing fleet of the jet family. The last ...
The Manila Times

Levicept Presents New Data Suggesting a Novel Neurotrophin-3 Inhibitor, LEVI-04, May Modify Disease and Improve Symptoms in Osteoarthritis

In newly reported pre-clinical data, there was no evidence of worsening of joint pathology with LEVI-04 treatment. LEVI-04 demonstrated improvement in joint pathology with chondroprotection, and ...

Lord Norman Foster opens new retrospective exhibition in Sydney

One should never keep a lord waiting. So when the wi-fi crashes as WISH’s scheduled video call with Lord Norman Foster is ...
Asianet Newsable on MSN

American Rebel Holdings, Inc. (NASDAQ: AREB) Makes $1.5 Million Strategic Investment in RAEK – Building the First-Party Data Engine for the AI Economy

American Rebel – America’s Next Great Success Story – Becomes a Strategic Owner in RAEK, the Fast-Growing Leader in First-Party Data. Together, this powerful combination unites a rising consumer brand ...